Rapp.Ns
RAPP.NS is an industrial machinery and equipment company that generates revenue primarily through the sale and service of industrial goods.
Business. RAPP.NS is an industrial machinery and equipment company that generates revenue primarily through the sale and service of industrial goods.
Analyst recommendations
13 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
RAPP.NS is an industrial machinery and equipment company that generates revenue primarily through the sale and service of industrial goods.
RAPP.NS has a liquidity position that is characterized by a current ratio of 3.38, indicating a strong ability to meet short-term obligations with its current assets. However, the company's operating cash flow is negative at -128,176,000, which may signal potential liquidity challenges in the near term. The company's debt-to-equity ratio is 0.19, suggesting a relatively low level of leverage and a conservative capital structure.
In terms of profitability, RAPP.NS has a return on equity of 13.34% and a return on assets of 10.02%, which are both positive indicators of the company's efficiency in generating profits from its equity and assets. These figures should be compared against the industry median to determine if the company is outperforming or underperforming its peers.
The company's revenue is concentrated in the industrial goods segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to specific market risks, particularly if demand for industrial machinery and equipment fluctuates in its primary markets.
Looking at the growth trajectory, the provided data does not include specific revenue growth figures for the current or next fiscal year. Therefore, it is not possible to determine the exact direction or magnitude of the company's growth without additional information.
The risk assessment for RAPP.NS indicates a medium level of liquidity risk and a low level of dilution risk. The company's key financial flag is the negative net cash position after subtracting total debt, which could affect its ability to fund operations and investments without external financing.
There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial status. The absence of such information suggests a stable operational environment for RAPP.NS.
- RAPP.NS has a strong current ratio but faces a negative operating cash flow, which could affect its liquidity.
- The company's return on equity and return on assets are positive, indicating efficient use of equity and assets.
- The company's revenue is concentrated in the industrial goods segment, with no disclosed geographic diversification.
- The company's debt-to-equity ratio is low, suggesting a conservative capital structure.
- The risk assessment indicates a medium level of liquidity risk and a low level of dilution risk.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Stock Option (Right to Buy) → Common StockAcquired 15 200 @ $35,21grant · 2026-06-10
- Director · Stock Option (Right to Buy) → Common StockAcquired 15 200 @ $35,21grant · 2026-06-10
- Director · Stock Option (Right to Buy) → Common StockAcquired 15 200 @ $35,21grant · 2026-06-10
- Director · Stock Option (Right to Buy) → Common StockAcquired 15 200 @ $35,21grant · 2026-06-10
- Director · Stock Option (Right to Buy) → Common StockAcquired 15 200 @ $35,21grant · 2026-06-10
- Director · Stock Option (Right to Buy) → Common StockAcquired 15 200 @ $35,21grant · 2026-06-10
- Director · Stock Option (Right to Buy) → Common StockAcquired 15 200 @ $35,21grant · 2026-06-10
- Director · Stock Option (Right to Buy) → Common StockAcquired 15 200 @ $35,21grant · 2026-06-10
- Chief Scientific Officer · Stock Options (Right to Buy) → Common StockDisposed 6 000 @ $1,80exercise · 2026-02-19
- Chief Medical Officer · Stock Option (Right to Buy) → Common StockAcquired 130 000 @ $27,75grant · 2026-02-02
- Chief Scientific Officer · Stock Option (Right to Buy) → Common StockAcquired 103 000 @ $27,75grant · 2026-02-02
- Director, Chief Executive Officer · Stock Option (Right to Buy) → Common StockAcquired 428 000 @ $27,75grant · 2026-02-02
- Chief Financial Officer · Stock Option (Right to Buy) → Common StockAcquired 148 000 @ $27,75grant · 2026-02-02
- Chief Development Officer · Stock Option (Right to Buy) → Common StockAcquired 120 000 @ $27,75grant · 2026-02-02
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- RAPP.NS Market data — financials · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,02 %$97M
- Investment Managers · as of 2026-03-310,01 %$0M
- Investment Managers · as of 2026-03-310,01 %$92M
- Institutional Investor · as of 2026-03-310,01 %$224M
- Investment Managers · as of 2026-03-310,01 %$22M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$23M
- Investment Managers · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$5M
- Funds · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$24M
- Investment Managers · as of 2025-12-310,00 %$55M
- Investment Managers · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$5M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-12-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Abraham N CeesayPresident, Chief Executive Officer, Director
Insider activity
- Director, Chief Executive Officer · Common StockSold 2 203 @ $42,11$93K · 2026-07-27
- Director, Chief Executive Officer · Common StockSold 7 @ $42,73$299 · 2026-07-27
- Director, Chief Executive Officer · Common StockSold 2 729 @ $40,57$111K · 2026-07-14
- Director, Chief Executive Officer · Common StockSold 5 481 @ $39,72$218K · 2026-07-14
- Chief Operating Officer · Common StockSold 3 792 @ $41,39$157K · 2026-06-30
- Chief Operating Officer · Common StockSold 1 000 @ $43,15$43K · 2026-06-30
- Chief Operating Officer · Common StockSold 3 308 @ $42,17$140K · 2026-06-30
- Chief Operating Officer · Common StockSold 1 900 @ $40,09$76K · 2026-06-30
- Director, Chief Executive Officer · Common StockSold 7 344 @ $39,77$292K · 2026-06-29
- Director, Chief Executive Officer · Common StockSold 876 @ $40,34$35K · 2026-06-29
- 10% owner · Common StockSold 18 572 @ $40,05$744K · 2026-05-26
- 10% owner · Common StockSold 133 618 @ $40,24$5,4M · 2026-05-11
- 10% owner · Common StockSold 5 018 @ $40,31$202K · 2026-05-08
- 10% owner · Common StockSold 271 495 @ $40,12$10,9M · 2026-05-07
- 10% owner · Common StockSold 426 005 @ $40,32$17,2M · 2026-04-17
- Chief Development Officer · Common StockSold 20 225 @ $39,99$809K · 2026-04-17
- Chief Development Officer · Common StockSold 10 200 @ $35,08$358K · 2026-04-14
- Chief Development Officer · Common StockSold 9 165 @ $34,97$321K · 2026-04-13
- Chief Development Officer · Common StockSold 500 @ $34,98$17K · 2026-04-10
- Chief Development Officer · Common StockSold 360 @ $34,90$13K · 2026-04-08
- Chief Operating Officer · Common StockSold 2 839 @ $28,55$81K · 2026-03-30
- Chief Operating Officer · Common StockSold 7 161 @ $28,04$201K · 2026-03-30
- Chief Development Officer · Common StockSold 10 115 @ $29,99$303K · 2026-03-25
- Chief Operating Officer · Common StockSold 2 014 @ $28,93$58K · 2026-03-05
- Chief Scientific Officer · Common StockOther 6 000 @ $1,80$11K · 2026-02-19
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 192.2%Derived (calculated)
- Return on equity (FY 2025-12-31): -23.0%Derived (calculated)
- Return on assets (FY 2025-12-31): -21.8%Derived (calculated)
- Current ratio (FY 2025-12-31): 26.17xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.06xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -74.4%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -7.3%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 24.3%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 24.3%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -42.4%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -34.9%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -50.6%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 55.6%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 58.7%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 62.7%Derived (calculated)
- Shares outstanding (annual): 47.77MSEC XBRL filing
- Total operating expenses (annual): USD 125.1MSEC XBRL filing
- Operating cash flow (annual): USD -87.47MSEC XBRL filing
- Total assets (annual): USD 512.43MSEC XBRL filing
- Operating income (annual): USD -125.1MSEC XBRL filing
- R&D expense (annual): USD 94.79MSEC XBRL filing
- Net income (annual): USD -111.48MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -3SEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -3SEC XBRL filing